SCHEMBL6154775

SCHEMBL6154775

C=CCOC(=O)C1CNCCC1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.34
TP53 P04637 2/20 0.34
ALDH1A1 P00352 5/20 0.33
GAA P10253 2/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
CYP3A4 P08684 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
KDM4E B2RXH2 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ERN1 O75460 1/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1019140 0.84 TSHR (0.38) TSHRTP53ALDH1A1GAARECQL
SCHEMBL22127638 0.81 L3MBTL1 (0.33) TSHRTP53ALDH1A1GAARECQL
SCHEMBL415009 0.80 MAPT (0.43) TSHRALDH1A1GAARECQLMEN1
Hydrochloric Acid SCHEMBL443973 0.78 MAPT (0.44) TSHRALDH1A1GAAMEN1KMT2A
SCHEMBL6153842 0.77 NPSR1 (0.34) TSHRALDH1A1GAASMN1; SMN2CYP3A4
SCHEMBL29529763 0.76 TSHR (0.36) TSHRTP53ALDH1A1GAARECQL
SCHEMBL22468826 0.76 TSHR (0.36) TSHRTP53ALDH1A1GAARECQL
SCHEMBL2721962 0.76 TSHR (0.36) TSHRTP53ALDH1A1GAARECQL
SCHEMBL22127485 0.76 ALDH1A1 (0.33) TSHRTP53ALDH1A1GAARECQL
SCHEMBL7517130 0.76 TSHR (0.36) TSHRTP53ALDH1A1GAARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101304-A2 PIPERIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-08-25 WO disclosed
CN-100415736-C Quinolylpropylpiperidine derivatives and their use as antimicrobial agents AVENTIS PHARMA SA (FR) 2008-09-03 CN disclosed
CN-1681801-A Quinolylpropylpiperidine derivatives and their use as antimicrobial agents AVENTIS PHARMA SA (FR) 2005-10-12 CN disclosed
US-6841562-B2 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor AVENTIS PHARMA S.A. (FR) 2005-01-11 US disclosed
US-20040082610-A1 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor NOVEXEL (FR) 2004-04-29 US disclosed
US-4012392-A ANALGESICS, MORPHINE ANTAGONISTS ACF CHEMIEFARMA N.V. (NL) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082610-A1 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor RRS1, MRPL21, FARSB TSHR 2967/4885TP53 3373/4885ALDH1A1 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.